However, Syk inhibition reduced neuronal and/or synaptic loss in mouse models of traumatic brain injury (He et al., 2022), stroke (Ye et al., 2020), LPS-induced inflammation (Kim et al., 2022), and tauopathy (Schweig et al., 2019). The gene discussed is SYK; the disease is stroke disorder.